Sugden M C, Fryer L G, Priestman D A, Orfali K A, Holness M J
Department of Biochemistry, Queen Mary and Westfield College, (University of London), UK.
Mol Cell Endocrinol. 1996 May 31;119(2):219-24. doi: 10.1016/0303-7207(96)03817-8.
Experimental hyperthyroidism induced by the administration of tri-iodothyronine (T3; 100 micrograms/100 g body wt; 3 days) increased plasma non-esterified fatty acids in the fed state in the rat. At the same time, hepatic PDH kinase responded with a persistent (1.6-fold) increase in activity. The exposure of hepatocytes from fed euthyroid rats to T3 (100 nM) in culture for 21 h increased PDH kinase activity to an extent comparable to that observed in vivo in response to hyperthyroidism. The in vitro increase in PDH kinase activity was suppressed by insulin (100 microU/ml) and by inhibition of mitochondrial fatty acid oxidation. The results demonstrate a direct hepatic action of T3 to increase PDH kinase activity, which is mediated by intramitochondrial fatty acyl-CoA or a product of beta-oxidation, and facilitated by hepatic insulin resistance.
给予三碘甲状腺原氨酸(T3;100微克/100克体重;3天)诱导的实验性甲状腺功能亢进增加了大鼠进食状态下血浆非酯化脂肪酸水平。与此同时,肝脏丙酮酸脱氢酶激酶活性持续增加(1.6倍)。将进食的甲状腺功能正常大鼠的肝细胞在培养中暴露于T3(100 nM)21小时,可使丙酮酸脱氢酶激酶活性增加到与体内甲状腺功能亢进时观察到的程度相当。体外丙酮酸脱氢酶激酶活性的增加被胰岛素(100微单位/毫升)和线粒体脂肪酸氧化抑制所抑制。结果表明,T3对肝脏有直接作用,可增加丙酮酸脱氢酶激酶活性,这是由线粒体内脂肪酰辅酶A或β氧化产物介导的,并因肝脏胰岛素抵抗而促进。